We and our collaborators have previously measured the p53 mutation level in nontumorous human liver tissue. The data are consistent with the hypothesis that p53 mutation load may indicate previous carcinogen exposure and identify individuals at increased cancer risk. We are again using the most sensitive, RFLP/PCR based, genotypic mutation analysis system available thus far, to measure the mutation load at codons 247 and 248 of the p53 gene in nontumorous colon tissue from donors with colon cancer, with cancer prone conditions, e.g., ulcerative colitis, and normal donors. We detected G:C to A:T transitions in those nontumorous samples which were obtained from the donors where tumors also have G:C to A:T transitions. These transitions were observed with several-fold higher absolute mutation frequencies that the control samples from normal donors. Ulcerative colitis samples showed several- fold higher absolute mutation frequency of G:C to A:T transition than in infants and normal adults. These results indicate that the nontumorous colon tissue in the cancer patients with p53 codon 248 mutations and the patient with ulcerative colitis carry a higher p53 mutation load at codon 248 that those from noncancer donors without known colon diseases. Nitric oxide synthase-2 activity was increased in the inflamed versus non-inflamed colonic regions from patients with ulcerative colitis. Microsatellite instability was also observed in the inflamed regions and was positively correlated with p53 mutation load. These results are consistent with genomic instability associated with oxyradical overload from increased NOS2 expression.
| Stauffer, Jimmy K; Scarzello, Anthony J; Jiang, Qun et al. (2012) Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology 56:1567-74 |
| Simone, Nicole L; Soule, Benjamin P; Ly, David et al. (2009) Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 4:e6377 |
| Hussain, S Perwez; He, Peijun; Subleski, Jeffery et al. (2008) Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res 68:7130-6 |
| Thomas, Douglas D; Ridnour, Lisa A; Isenberg, Jeffrey S et al. (2008) The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45:18-31 |
| Wink, David A; Ridnour, Lisa A; Hussain, S Perwez et al. (2008) The reemergence of nitric oxide and cancer. Nitric Oxide 19:65-7 |
| Thomas, Douglas D; Ridnour, Lisa A; Espey, Michael Graham et al. (2006) Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem 281:25984-93 |
| Goodman, Julie E; Mechanic, Leah E; Luke, Brian T et al. (2006) Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer 118:1790-7 |
| Ying, Lei; Marino, Jillian; Hussain, S Perwez et al. (2005) Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res 65:9132-6 |
| Hofseth, Lorne J; Robles, Ana I; Espey, Michael G et al. (2005) Nitric oxide is a signaling molecule that regulates gene expression. Methods Enzymol 396:326-40 |
| Hussain, S Perwez; Trivers, Glennwood E; Hofseth, Lorne J et al. (2004) Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res 64:6849-53 |
Showing the most recent 10 out of 29 publications
